| Oct 4 |
Hims & Hers Health Set to Join S&P SmallCap 600
|
| Oct 4 |
Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list
|
| Oct 3 |
For Hims & Hers Stock, GLP-1 Giveth and GLP-1 Taketh Away
|
| Oct 3 |
Stocks to Watch Thursday: Levi Strauss, Hims & Hers, Constellation Brands, Nvidia
|
| Oct 3 |
Is Hims & Hers rally at risk as GLP-1 shortages ease?
|
| Oct 3 |
Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
|
| Oct 3 |
Eli Lilly GLP-1 shortage officially ends, hurting Hims & Hers
|
| Oct 3 |
Hims & Hers: Shortage Saga Brings Stupendous Risk-Reward
|
| Sep 25 |
Hims & Hers: The Gift That Keeps On Giving
|
| Sep 24 |
Hims & Hers Is Unbelievably Cheap And Profitable: Buy Now
|
